Comments

Pharvaris Stock Price, Quotes and Forecasts

Q: What sector and industry does Pharvaris (PHVS) operate in?

Pharvaris is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

PHVSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Pharvaris (PHVS) Forecast

News Earnings Pharvaris (PHVS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Pharvaris Stock Price, Quotes and Forecasts | NASDAQ:PHVS | Benzinga

Explore Pharvaris stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PHVS.

Open	$15.55
Close	-
Volume / Avg.	7.21K / 44.93K
Day Range	$15.22 - $15.55
52 Wk Range	14.14 - 25.55
Market Cap	$829.77M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	1.17%
Days to Cover	12.98

Recent News

FDA Clears Pharvaris' Trial For Investigational Drug For Swollen Blood Vessels, Stock Jumps

Pharvaris receives FDA approval to advance deucrictibant for hereditary angioedema prophylaxis, lifting clinical hold. Learn about the latest developments in HAE treatment.

Vandana Singh

Gold Moves Higher; Campbell Soup Earnings Top Expectations

U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.

Lisa Levin

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$15.55
Close	-
Volume / Avg.	7.21K / 44.93K
Day Range	$15.22 - $15.55
52 Wk Range	14.14 - 25.55
Market Cap	$829.77M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	1.17%
Days to Cover	12.98

About

Sector

Healthcare

Industry

N/A

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pharvaris (PHVS) stock?

You can purchase shares of Pharvaris (NASDAQ:PHVS) through any online brokerage.

View our list of the best stock brokerages

Who are Pharvaris (PHVS) competitors?

There are no as such competitors for Pharvaris.

What is the forecast, or price target, for Pharvaris (PHVS) stock?

Pharvaris has a consensus price target of $36.89.

What is the current price for Pharvaris (PHVS)?

The stock price for Pharvaris (NASDAQ: PHVS) is $15.3 last updated March 25, 2025 at 1:00 PM EDT.

Does Pharvaris (PHVS) pay a dividend?

There are no upcoming dividends for Pharvaris.

When is Pharvaris (NASDAQ:PHVS) reporting earnings?

Pharvaris’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Pharvaris (PHVS) going to split?

There is no upcoming split for Pharvaris.

What sector and industry does Pharvaris (PHVS) operate in?

Pharvaris is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.